-
公开(公告)号:EP1053239B1
公开(公告)日:2003-01-08
申请号:EP99906996.6
申请日:1999-02-12
发明人: COUGHLAN, Michael, J. , ELMORE, Steven, W. , KORT, Michael, E. , KYM, Philip, R. , MOORE, Jimmie, L. , PRATT, John, K. , WANG, Alan, X. , EDWARDS, James, P. , JONES, Todd, K.
IPC分类号: C07D491/04 , A61K31/44 , A61K31/505
CPC分类号: C07D491/04
摘要: Compounds having Formula (I), are useful for partially or fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of inhibiting immune or autoimmune diseases in a mammal.
-
公开(公告)号:EP1053239A1
公开(公告)日:2000-11-22
申请号:EP99906996.6
申请日:1999-02-12
发明人: COUGHLAN, Michael, J. , ELMORE, Steven, W. , KORT, Michael, E. , KYM, Philip, R. , MOORE, Jimmie, L. , PRATT, John, K. , WANG, Alan, X. , EDWARDS, James, P. , JONES, Todd, K.
IPC分类号: C07D491/04 , A61K31/44 , A61K31/505
CPC分类号: C07D491/04
摘要: Compounds having Formula (I), are useful for partially or fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of inhibiting immune or autoimmune diseases in a mammal.
-
公开(公告)号:EP1053240B1
公开(公告)日:2003-04-16
申请号:EP99905971.0
申请日:1999-02-15
IPC分类号: C07D491/052 , A61K31/44
CPC分类号: C07D491/04
摘要: Compounds having Formula (I) are useful for partially of fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor in a mammal and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of inhibiting immune or autoimmune diseases in a mammal.
-
公开(公告)号:EP1053240A1
公开(公告)日:2000-11-22
申请号:EP99905971.0
申请日:1999-02-15
IPC分类号: C07D491/052 , A61K31/44
CPC分类号: C07D491/04
摘要: Compounds having Formula (I) are useful for partially of fully antagonizing, repressing, agonizing, or modulating the glucocorticoid receptor in a mammal and treating immune, autoimmune and inflammatory diseases in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of inhibiting immune or autoimmune diseases in a mammal.
-
-
-